Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Connectivity-guided theta-burst stimulation targeting the hippocampus in schizophrenia

Official title: Theta Burst Modulation of Hippocampal-Cortical Rhythms in Schizophrenia

Run by Stanford University · NCT07010614 · Data updated 2026-11-12

We will try targeted theta-burst TMS guided by brain connectivity to change hippocampus activity in adults with schizophrenia or related psychotic disorders, measuring brain signals with EEG and, for some participants, intracranial electrodes.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorStanford University
Academic / other
Locations1 site (Stanford, California)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedFebruary 27, 2026
Trial IDNCT07010614 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18–65 with a DSM-5 schizophrenia-spectrum diagnosis for the noninvasive TMS-EEG arms, and adults with medically intractable epilepsy undergoing phase II intracranial EEG monitoring for the intracranial arms.

Probably not a fit

People with intellectual disability, recent serious suicidal ideation or attempts, significant head injury or other uncontrolled neurological/medical conditions, pregnancy or inability to consent are unlikely to be eligible or to receive benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This protocol uses connectivity-guided theta-burst transcranial magnetic stimulation (TBS) to target hippocampal networks implicated in schizophrenia. Non-invasive arms receive TMS with concurrent EEG and sham control to record immediate neural responses, while a separate intracranial arm enrolls patients undergoing phase II intracranial EEG monitoring for direct hippocampal recordings. Researchers will compare brain activity before and after stimulation to determine whether hippocampal function can be systematically modulated. Results are intended to clarify hippocampal contributions to symptoms and to inform future neuromodulation treatments.

Why it matters

Potential benefit: If successful, this approach could provide a noninvasive way to alter hippocampal activity and potentially reduce symptoms or cognitive deficits in schizophrenia.

How similar studies have gone: Related connectivity-guided TMS and theta-burst protocols have shown promise in modulating cortical networks and memory in other populations, but hippocampal targeting in schizophrenia remains largely novel and unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women, ages 18 to 65 years
* Medically intractable epilepsy requiring phase II monitoring (intracranial EEG arms only)
* DSM-V diagnosis of schizophrenia spectrum Axis I disorders including delusional disorder, brief psychotic disorder, schizophreniform disorder, schizophrenia, schizoaffective disorder (non-invasive TMS-EEG arms only).
* Must have intellectual capacity to ensure adequate comprehension of the study and potential risks involved in order to provide informed consent
* No current or history of major neurological disorders other than epilepsy.

Exclusion Criteria:

* DSM5 diagnosis of intellectual disability
* Significant head injury
* Active suicidal ideation or history of suicide attempt within the past 1 year.
* Medical illness affecting brain structure or function, or other uncontrolled or unstable medical condition.
* Pregnancy or postpartum (\<6 weeks after delivery or miscarriage)
* Inability to provide informed consent
* Active substance abuse other than alcohol or cannabis within the past 1 year
* Psychotic illness with a temporal relation to substance use or head injury
* Those with a contraindication for MRIs or TMS (e.g. implanted metal).

Where it's running

  • Stanford University
    Stanford, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.